About Suzanne Rettenmier
Suzanne Rettenmier is an executive officer at Automera US.
Form D filings also name Suzanne Rettenmier as an executive officer at KayoThera.
Suzanne Rettenmier first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Suzanne Rettenmier in the role, so the role may have started earlier or lasted longer.
Automera US Inc.
Executive officer
2023 – 2026 · Seattle, WA
Develops potential cancer treatments using drug discovery tools and targeted protein degradation.
Key Colleagues at Startups
The people Suzanne Rettenmier works with at each company, as listed on that company's latest Form D.
Automera US Inc. · Form D, Aug 7, 2026
BW
Benjamin Zian-Loong Wang
Director
SC
Sean Cassidy
Director
TL
Thong Le
Chief Executive Officer and director
YC
Yu-Chieh Alice Chen
Director
MH
Mitchell Hymowitz
Executive officer
KayoThera, Inc. · Form D, Mar 24, 2022
ME
Mark Esposito
Director
KM
Ken Mohler
Executive officer and director
IH
Ian Howes
Executive officer
TL
Thong Le
Chief Executive Officer and director